|
Real-time Estimate
Tradegate
03:01:46 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 74.29 EUR | +0.76% |
|
-0.86% | -11.16% |
| 09-22 | European Pharma Leaders Push for National Reforms to Boost Investment | DJ |
| 09-22 | European drugmakers call for faster trials, more spending to compete with US, China | RE |
| Market Cap | 89.12B 102B 83.77B 76.44B 143B 9,749B 143B 1,005B 388B 4,979B 383B 375B 16,051B | P/E 2026 * |
11.8x | P/E 2027 * | 10.3x |
|---|---|---|---|---|---|
| Enterprise Value | 101B 115B 94.54B 86.27B 162B 11,003B 162B 1,135B 438B 5,619B 432B 423B 18,115B | EV / Sales 2026 * |
2.11x | EV / Sales 2027 * | 1.92x |
| Free-Float |
88.34% | Yield 2026 * |
5.72% | Yield 2027 * | 6.04% |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| SAN | Real-time | |
Xetra
| SNW | Delayed | |
|
CBOE
| SAN | Real-time | |
|
OTC Markets
| SNYNF | Delayed | |
|
Borsa Italiana
| 1SAN | End-of-day quote | |
|
London S.E.
| 0O59 | Delayed | |
|
Wiener Boerse
| SANO | End-of-day quote | |
|
Mexican S.E.
| SAN1 N | End-of-day quote | |
|
Bulgaria S.E.
| SNW | End-of-day quote | |
|
Swiss Exchange
| SAN | Delayed | |
|
Tradegate
| SNW | Real-time | |
|
CBOE
| 0O59 | Real-time | |
|
Boerse Muenchen
| SNW | Real-time | |
|
Deutsche Boerse AG
| SNW | Delayed | |
|
Börse Stuttgart
| SNW | Delayed |
Last Transcript: Sanofi
| 1 day | +0.85% | ||
| 1 week | -0.86% | ||
| Current month | -3.30% | ||
| 1 month | -6.11% | ||
| 3 months | +1.78% | ||
| 6 months | -4.82% | ||
| Current year | -11.16% |
| 1 week | 73.73 |  | 75.15 |
| 1 month | 73.6 | | 79.23 |
| Current year | 71.65 | | 84.73 |
| 1 year | 71.65 | | 90.66 |
| 3 years | 71.65 | | 110.34 |
| 5 years | 71.65 | | 110.34 |
| 10 years | 63.18 | | 110.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Paulo Fontoura
CTO | Chief Tech/Sci/R&D Officer | - | 2026-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 57 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 65 | 2020-04-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.76% | -0.86% | - | - | 102B | |
| +0.45% | +3.00% | +55.00% | +112.54% | 1,043B | |
| -0.10% | +0.74% | +54.52% | +67.72% | 649B | |
| +0.28% | +0.82% | +19.15% | +73.63% | 469B | |
| +0.25% | +0.97% | +34.30% | +45.99% | 355B | |
| -0.22% | +2.30% | +18.47% | +26.67% | 270B | |
| -0.45% | +4.59% | +10.19% | +14.72% | 262B | |
| +4.34% | +9.21% | +43.44% | +53.25% | 222B | |
| +1.40% | +4.35% | +35.72% | +103.53% | 189B | |
| -0.27% | -6.20% | -32.46% | -59.65% | 175B | |
| Average | +0.62% | +2.20% | +26.48% | +48.71% | 403.67B | |
| Weighted average by Cap. | +0.41% | +2.19% | +36.40% | +67.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.65B 54.52B 44.78B 40.87B 76.7B 5,212B 76.72B 537B 207B 2,662B 205B 200B 8,581B | 50.64B 57.95B 47.6B 43.44B 81.52B 5,540B 81.54B 571B 220B 2,829B 218B 213B 9,121B |
| Net income | 7.48B 8.56B 7.03B 6.41B 12.04B 818B 12.04B 84.36B 32.55B 418B 32.14B 31.43B 1,347B | 8.89B 10.17B 8.35B 7.62B 14.3B 972B 14.31B 100B 38.68B 496B 38.19B 37.35B 1,600B |
| Net Debt | 11.46B 13.12B 10.77B 9.83B 18.45B 1,254B 18.46B 129B 49.9B 640B 49.26B 48.18B 2,064B | 8.34B 9.54B 7.83B 7.15B 13.42B 912B 13.42B 94.03B 36.28B 466B 35.82B 35.04B 1,501B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-21 | €73.73 | -1.26% | 412 |
| 26-09-21 | €74.67 | +0.20% | 513 |
| 26-09-18 | €74.52 | -0.23% | 6 |
| 26-09-17 | €74.69 | +0.89% | 7 |
| 26-09-16 | €74.03 | -0.46% | 40 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
- SANO Stock
Select your edition
All financial news and data tailored to specific country editions
